Biomarkers of response to immunotherapy in pancreatic ductal adenocarcinoma (PDAC) with homologous recombination deficiency (HRD). Concurrent mutations in DNA damage repair genes BRCA1, POLE, ATM and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback